NovaBay Pharmaceuticals Signs Option Agreement With Virbac Animal Health for Aganocide(R) Compounds

EMERYVILLE, Calif. — NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company today announced that it has entered into a feasibility and option agreement with Virbac Animal …